MONDOBIOTECH SA has a total of 14 patent applications. Its first patent ever was published in 2000. It filed its patents most often in EPO (European Patent Office), Australia and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are INST OF NUTRACEUTICAL RES PTY, BOEHRINGER INGELHEIM INT GMBH * and CHYNA LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | Australia | 2 | |
#3 | Brazil | 2 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Electrotherapy | |
#5 | Heterocyclic compounds | |
#6 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Block Lutz-Henning | 8 |
#2 | Ziesche Rolf | 3 |
#3 | Bevec Dorian Dr | 2 |
#4 | Bevec Dorian | 2 |
#5 | Block L-H | 1 |
#6 | Rolf Ziesche | 1 |
#7 | Dorian Bevec | 1 |
Publication | Filing date | Title |
---|---|---|
BR0302832A | Use of compounds having vasoactive intestinal peptide biological activity for the treatment of chronic obstructive pulmonary disease | |
EP1413300A1 | Pyrimidinium-guanidiniminoethylphenyl-guanidinoalkyl-amines and guanidiniminoethylphenyl-guanidinoalkylamines as pharmaceutically active new substances | |
EP1403638A1 | Molecular methods for diagnosing interstitial lung diseases | |
EP1337557A2 | Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension | |
AU9167101A | Textile fabrics with emf-attenuating materials | |
EP1227831A2 | Interferon gamma for the treatment of asthma |